First image of the tested substance
First image of the tested substance
Second image of the tested substance
First image of the tested substance
Second image of the tested substance
Second image of the tested substance

Active ingredients and content

4-HO-MET

Quantity not determinable

4-AcO-MET

Quantity not determinable

Details of the substance tested

Thickness

Length x width

Diameter

Weight

Colour

Pink

Colour

Fracture groove

Yes

Relevant substance(s)

New Psychoactive Substances (NPS)

Learn more

Risk assessment

A pill labeled as 4-ACO-MET contained the hallucinogenic tryptamine 4-hydroxy-N-ethyl-N-methyltryptamine (4-HO-MET) instead of 4-ACO-MET and also contained small traces of 4-ACO-MET.

The substance 4-ACO-MET is normally dosed lower (orally: 10 - max. 25 mg) than 4-HO-MET (orally: 8 - max. 20 mg). As 4-HO-MET is somewhat more potent, there is a risk of overdosing, which can lead to an unexpected and possibly unpleasant trip with harmful side effects. In addition, the ratio between 4-HO-MET and 4-ACO-MET is unknown, which makes the effect unpredictable. The incomplete conversion indicates an uncontrolled synthesis. Consumption therefore poses an additional health risk. The interaction potential of the two substances in unknown mixing ratios is completely unknown.

4-HO-MET is structurally related to 4-ACO-MET and there is evidence that 4-ACO-MET is converted to 4-HO-MET in the body. 4-HO-MET is related in chemical structure to psilocin, which is a psychoactive ingredient of psilocybin-containing mushrooms ("magic mushrooms"). Therefore, 4-HO-MET produces a similar effect to 4-ACO-MET. The traces of 4-ACO-MET found possibly indicate a synthesis problem in which the originally intended substance 4-ACO-MET was converted to 4-HO-MET during production or storage.

There is hardly any information available on the risks, side effects and long-term consequences of 4-HO-MET. Consumption is therefore not recommended! False declarations also occur time and again with pills; it is therefore essential to have them tested before consumption!

Alert level

Safer Use

Analysis

Have your substances tested in a drug check.

Testing

If you do not have the possibility to have substances analyzed, first test a maximum of one third of the pill, since very many high-dose pills are in circulation.

Wait and see

Wait 2 hours after taking the medication, as there are always pills with unexpected active ingredients in circulation, which can have a later onset of action.

Drinking

Remember: drink non-alcoholic and isotonic drinks (3 dl / hour) and take breaks in the fresh air from time to time to prevent overheating / dehydration.

Similar warnings

There are no current warnings for this substance

Things to know